# Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

> **NCT01529476** · PHASE3 · COMPLETED · sponsor: **TaiGen Biotechnology Co., Ltd.** · enrollment: 540 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Nemonoxacin

## Key facts

- **NCT ID:** NCT01529476
- **Lead sponsor:** TaiGen Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2013-06-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01529476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01529476, "Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01529476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*